On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Perspective and Pathogenesis
-
23 min
1. Expanding frontiers of cerebrovascular disease- Prof. Vladimir Hachinski
-
32 min
2. Basic anatomy, physiology and pathophysiology of the cerebral circulation for the physician- Prof. Jean-Claude Baron
-
43 min
3. Pathophysiology of cerebral ischemia- Prof. Wolf-Dieter Heiss
-
20 min
4. Intracerebral hemorrhages: causes and clinical findings- Prof. Louis Caplan
-
40 min
5. Subarachnoid hemorrhage (SAH)- Prof. R. Loch Macdonald
- Diagnosis
-
32 min
6. Clinical diagnosis of stroke and subtypes- Prof. Louis Caplan
-
30 min
7. The investigation of stroke- Dr. Bart Demaerschalk
- Treatment
-
35 min
8. Acute therapy of stroke and reperfusion treatments- Prof. Brian Silver
-
39 min
9. Subarachnoid hemorrhage diagnosis and management- Prof. Gary K. Steinberg
-
26 min
10. Stroke-induced heart injury- Dr. Luciano A. Sposato
- Rehabilitation
-
37 min
11. Stroke rehabilitation: principles of stroke- Prof. Robert Teasell
-
27 min
12. Stroke rehabilitation: therapies and treatments- Prof. Robert Teasell
- Prevention
-
23 min
13. Lifestyle and nutrition in stroke prevention- Prof. J. David Spence
-
40 min
- Special Topics
-
54 min
15. Pediatric stroke: cerebrovascular injury in the developing brain- Prof. Adam Kirton
-
43 min
16. Stroke in women: epidemiology, risk and prevention- Prof. Cheryl Bushnell
-
25 min
17. Transient ischemic attack and cognition- Dr. Jennifer Mandzia
-
31 min
18. Vascular cognitive impairment- Prof. Eric E. Smith
-
34 min
19. Atrial fibrillation, anticoagulation and vitamins for homocysteine- Prof. J. David Spence
-
41 min
20. Stroke in the young adult- Prof. Jeffrey Saver
-
16 min
21. Stroke in the young- Dr. Gyan Kumar
-
23 min
22. Convergence and joint prevention of stroke and dementia- Prof. Vladimir Hachinski
- Archived Lectures *These may not cover the latest advances in the field
-
55 min
23. Vascular cognitive impairment- Dr. John Bowler
-
32 min
24. Pediatric stroke- Dr. Gabrielle deVeber
-
36 min
25. The deteriorating stroke- Prof. Werner Hacke
-
27 min
26. General management- Prof. Bo Norrving
-
35 min
27. The treatment of stroke: specific management - thrombolysis plus- Prof. Nils Wahlgren
-
42 min
28. Rehabilitation: the chronic phase- Prof. Lalit Kalra
-
61 min
29. Prevention: management of risk and protective factors- Prof. Graeme Hankey
-
30 min
30. Medical therapy for secondary prevention of ischemic stroke- Prof. Larry Goldstein
-
34 min
31. Subarachnoid haemorrhage- Prof. Jan van Gijn
-
35 min
32. Controversies in stroke- Prof. Stephen Davies
- Prof. Geoffrey Donnan
-
35 min
33. Medical and surgical stroke- Prof. Carlos Kase
-
35 min
34. The urgency of stroke prevention after TIA- Prof. S. Claiborne Johnston
-
54 min
35. Carotid endarterectomy, angioplasty and stenting- Prof. Martin Brown
-
42 min
36. The clinical diagnosis of stroke and stroke subtypes- Prof. Louis Caplan
Printable Handouts
Navigable Slide Index
- Introduction
- Neurological symptoms
- Six issues following the onset of symptoms
- Pathological and aetiological subtypes of stroke
- Treatment strategies for ischaemic stroke
- The prevention of recurrent ischemic events
- Risk of recurrent ischaemic stroke
- Survival and vascular event risk after TIA
- Causes of recurrent ischaemic stroke
- Recurrent atherothromboembolic events prevention
- Carotid revascularisation
- Vascular risk factor control
- Causal risk factors for recurrent stroke
- Blood pressure as a major risk factor
- Increase in BP is associated with stroke
- Lowering BP reduces the risk of stroke (1)
- Lowering BP reduces the risk of stroke (2)
- BP reduction and secondary prevention of stroke
- HOPE study: inclusion criteria
- Reduction in stroke, MI or vascular death
- HOPE study: subgroup analyses
- HOPE study: outcome events
- Consistent reduction in risk of stroke with ramipril
- PROGRESS trial: design
- PROGRESS trial: blood pressure differences
- PROGRESS trial: stroke risk reduction
- BP-lowering effect on risk of recurrent stroke (1)
- BP-lowering effect on risk of recurrent stroke (2)
- Combination therapy is more effective
- How low should BP be lowered?
- PROGRESS: Effect of combination therapy
- Lowering BP by non-pharmacological intervention
- AHA/ASA guidelines: hypertension
- Second major risk factor: hyperlipidemia
- Effects of statins on stroke (1)
- Effects of statins on stroke (2)
- Statins in patients with a history of stroke
- Vascular events by lipid concentration
- Effects of simvastatin allocation on stroke
- Reduction of LDL-C and relative risk of stroke
- Dietary and lifestyle modifications
- AHA/ASA stroke-prevention guidelines: Lipids (1)
- AHA/ASA stroke-prevention guidelines: Lipids (2)
- AHA/ASA stroke-prevention guidelines: Lipids(3)
- Diabetes Mellitus as a risk factor
- Impact of Ramipril on stroke in HOPE trial
- Statin treatment in diabetes patients
- LDL-C reduction effect on major vascular events (1)
- LDL-C reduction effect on major vascular events (2)
- LDL-C reduction effect on major vascular events (3)
- HbA1c reduction associated with stroke reduction
- AHA/ASA stroke prevention guidelines-diabetes
- Smoking as a risk factor
- Smoking and risk of stroke
- Increasing odds of MI with increased smoking
- AHA/ASA stroke prevention guidelines - smoking
- Alcohol intake as a risk factor
- Alcohol and risk of stroke in men (1)
- Alcohol and risk of stroke in men (2)
- Greater intake of alcohol
- Alcohol consumption and risk of stroke
- AHA/ASA stroke prevention guidelines - alcohol
- Is obesity a risk factor for stroke?
- Body mass index and risk of stroke (1)
- Body mass index and risk of stroke (2)
- AHA/ASA stroke prevention guidelines - obesity
- Can physical activity reduce the risk of stroke?
- Physical activity and risk of stroke
- Leisure time physical activity and risk of stroke
- Active commuting and risk of stroke
- AHA/ASA guidelines - physical activity
- Effect of lowering homocysteine on IHD and stroke
- Folic acid and relative risk of stroke
- AHA/ASA guidelines - hyperhomocystinaemia
- AHA/ASA guidelines - Antiphospholipid antibodies
- Increased risk of stroke with hormone therapy
- AHA/ASA guidelines - hormone therapy
- Cardioegenic embolism causes recurrent strokes
- Atrial fibrillation as a cardioembolic cause
- Hemorrhagic transformation of cerebral infarction
- Heparin and recurrent stroke rates
- Effect of anticoagulants vs. placebo or aspirin
- The long-term benefits of anticoagulation
- Outcome among AF patients after TIA or IS
- Aspirin effect on stroke or systemic embolism
- Warfarin effect on stroke or systemic embolism
- Effect of Warfain compared with Aspirin
- Optimal INR in nonrheumatic AF
- What is the appropriate treatment for each patient?
- Clinical predictors of ischaemic stroke in AF
- Echocardiograph helps to re-stratify the patient
- New anticoagulants
- AHA/ASA guidelines - atrial fibrillation
- AHA/ASA guidelines - acute MI and LFT
- AHA/ASA guidelines - cardiomyopathy
- AHA/ASA guidelines - valvular heart disease
- AHA/ASA guidelines - mitral valve prolapse
- AHA/ASA guidelines - prosthetic heart valves
- Patients with patent foramen ovale
- AHA/ASA guidelines - patent foramen ovale
- Summary
Topics Covered
- Patients with ischaemic stroke are at high risk of recurrent vascular events
- One strategy to reduce the risk of recurrent events is controlling causal risk factors
- Effective strategies include stopping smoking, lowering blood pressure and blood cholesterol, minimising alcohol and salt consumption and optimizing glycosylated haemoglobin, body weight and physical activity
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Hankey, G. (2008, October 27). Prevention: management of risk and protective factors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 18, 2025, from https://doi.org/10.69645/WRWW1985.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Graeme Hankey has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
